Healthcare News

TME Pharma updates shareholders on final NOX-A12 license talks, capital discipline, minimal dilution, and capturing positive biotech market momentum.

TME Pharma informe ses actionnaires des négociations finales pour NOX-A12, de sa rigueur financière, de la faible dilution et du marché biotech.

TOKYO and CAMBRIDGE, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB), announced today that “LEQEMBI® Pen”, the subcutaneous (SC) formulation of the...

Press Release Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026September 16, 2026 – release at 7:30 amSophia Antipolis, FranceNicox SA (Euronext Growth Paris: FR0013018124, ALCOX),...

Communiqué de presseNicox : Les données sur NCX 470 seront présentées lors du Congrès annuel 2026 de l’AAOpt16 septembre 2026 – publication à 7H30Sophia Antipolis, FranceNicox SA (Euronext Growth...

Rock Hill, SC, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Keystone Behavioral Health, a York County provider of substance misuse prevention, intervention, treatment and recovery services, today released...

Greenhouse Treatment Center appoints three new leaders to Executive Director, Medical Director, and Associate Medical Director roles.

PONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, will host its first Investor Day on Thursday, September...

HIGH POINT, N.C., Sept. 15, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential...